Inhibikase Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 10

EPO Patents = 1

Trademarks = 4

Forward Citations = 26

Loading Chart...

5 inventors (with patents filed for the assignee):

Milton Henry Werner (10 out of 11 patents)

Terence Alfred Kelly (8 out of 26 patents)

Sundeep Dugar (2 out of 80 patents)

4. Dinesh Mahajan (2 out of 15 patents)

5. Rhushikesh Chandrabhan Deokar (2 out of 3 patents)

10 patents: Sort by Forward Citations

1. 12629371 - Compositions and methods for inhibiting kinases (2026-05-19),

2. 11725005 - Compositions and methods for inhibiting kinases (2023-08-15),

3. 11407747 - Compositions and methods for inhibiting kinases (2022-08-09),

4. 10906896 - Compositions and methods for inhibiting kinases (2021-02-02),

5. 10344027 - Compositions and methods for inhibiting kinases (2019-07-09),

6. 10316031 - Compositions and methods for inhibiting kinases (2019-06-11),

7. 10118923 - Compositions and methods for inhibiting kinases (2018-11-06),

8. 9907796 - Methods of treating tumoral diseases, or bacterial or viral infections (2018-03-06),

9. 9828370 - Compositions and methods for inhibiting kinases (2017-11-28),

10. 9487500 - Compounds and compositions thereof (2016-11-08),

Company Overview

Inhibikase Therapeutics, Inc. is a biotechnology company based in Atlanta, GA, focused on developing innovative therapies for neurodegenerative diseases. The company specializes in advancing treatments that target the underlying mechanisms of these conditions, particularly in the realm of Parkinson's disease and related disorders. Through its proprietary drug development platform, Inhibikase aims to address significant unmet medical needs, leveraging cutting-edge research to improve patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

10 Patents

#215 in Atlanta, GA

#583 in Georgia

#29,922 in US

#56,169 in the World

Atlanta, GA, United States of America

Inhibikase Therapeutics, Inc.

Forward Citations = 26

5 inventors:

Milton Henry Werner (10 out of 11 patents)

Terence Alfred Kelly (8 out of 26 patents)

Sundeep Dugar (2 out of 80 patents)

4. Dinesh Mahajan (2 out of 15 patents)

5. Rhushikesh Chandrabhan Deokar (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Inhibikase Therapeutics, Inc.. Retrieved from https://idiyas.com/company/inhibikase-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]